Guy Heathers

CBO at Albatroz Therapeutics

Speaker

Guy is currently Chief Business Officer at Albatroz Therapeutics. Previously, Guy was VP of Business Development at Hummingbird Bioscience for over two years as well as VP of IP & Business Development at Tessa Therapeutics. In addition, Guy is currently consultant to a number of Singapore biotech companies.

Guy has also worked in government sector roles in Singapore as the Director of Technology Development at the National Cancer Centre Singapore and Director of Singapore Health Services IP office. Earlier, Guy held a number of positions in biotech companies in different continents including, Chief Business Officer at Cancer Therapeutics CRC Pty Ltd, Melbourne Australia and Chief Executive Officer at Amaranth Medical Pte Ltd (Singapore), Gateway Capital Pty Ltd (Australia) and Biotech Research Ventures Pte Ltd (Singapore). Prior to moving to Asia/Australia he held positions of Chief Operating Officer, Cancer Research Ventures Ltd and Head of Business Development, Cancer Research Campaign Technology Ltd.

In addition to these roles, Guy has been involved in creating and developing over 20 biotech start-ups during his career, including Cyclacel (listed on NASDAQ), Kudos (bought by Astra Zeneca), pSiOncology (listed on ASX), Enleofen (bought by Boehringer Ingelheim) as well as numerous multimillion-dollar collaboration and licensing deals.

Guy begun his career in the pharma industry in the previous century with a 7 year stint at Hoffmann-La Roche in Nutley, New Jersey, after a 3 year post-doctoral fellowship at Washington University Medical School in St. Louis Missouri.